Thursday, 2 April 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 02 April 2026
News

Global pharma inks Arrotex deal

Posted 2 April 2026 AM

Besins Healthcare is the latest global pharma to enter a strategic partnership with Arrotex which will represent its PBS-listed menopausal hormone therapy (MHT), Prometrium, across Australia.

Under the agreement, Arrotex has also been granted a license to an exclusive, authorised generic. It's expected to be available in Australia by quarter two 2026, with hopes for a PBS listing shortly after.

To see the whole article, please login

Popular

Aussie pharma exec wins CEO job
Aussie GM exits but where to next?
Pharma unveils a new name
13 pharmas win April PBS listings
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home